Equity
Equity Analysis
Price
 Gainers & Losers
 Weekly Gainers & Losers
 Monthly Gainers & Losers
 Out & Under Performers
 Advances & Declines
 New Highs & Lows
 52 Week Highs & Lows
 Weightage
 Only Buyers & Sellers
 Historical Returns
Volume
Analysis
Exchange Holidays
News Analysis
Corporate Action
Corporate Info
Other Market
  Home   >  CORPORATE ACTION  > Board Meetings
Board   Meetings      
As On Jun 12,2026
Options:
Aptus Pharma  
Preferential Issue of shares Inter alia, to consider and deliberate ........
Ather Energy  
inter alia,to consider and approve the proposal of raising of funds ........
Bright Outdoor Media  
Inter alia, to consider and approve the following matters: 1. Migr ........
Capital Small Fin.  
Employees Stock Option Plan
Ducon Infra.  
Right Issue of Equity Shares & Inter alia, to conduct the following: ........
Grovy India  
Inter alia, to consider and approve the restructuring of the senior ........
Jolly Plastic  
A.G.M. & inter alia to consider and approve the following: 1. Appoin ........
Kirloskar Ferrous  
Final Dividend
Mukka Proteins  
Inter alia, to consider and approve The proposal of raising of fund ........
Oasis Securities  
Inter alia, for discussion, consideration, and approval of the foll ........
Omkar SpecialityChem  
Audited Results
Pro Fin Capital Serv  
The meeting of Board of Directors of the Company is scheduled to be ........
Rungta Irrigation  
inter alia consider and approve: 1. The proposal of fund raising by ........
Samyak International  
inter alia, to consider and approve following matters:- 1. To ........
Sellwin Traders  
inter-alia, to consider the following agendas:- 1. To shifting of ........
Shivamshree Business  
Inter alia, to consider the Withdrawal and Cancellation of the Prop ........
Shivom Inv. &Consult  
Audited Results
Soma Textiles  
Final Dividend
Vegorama Punjabi Ang  
Half Yearly Results & Audited Results
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.